Teaser text

Creating technologies to build a human interface to artificial touch sensors that is non-invasive, robust, cost-effective, and safe. The technology could be applied to restore touch to amputees with a prosthetic hand or make early diagnosis of nerve damage resulting from chemotherapy or diabetes.

Body Text

Competitive advantage

  • Neural translation system uses trained artificial neurons based on nerve signal recordings from actual individual human tactile receptors encoding different aspects of object manipulation
  • Enabling patients to experience touch without requiring extensive training or brain plasticity
  • Unique pulsatile mechanical stimulation approach
  • Technology is non-invasive, which makes it cheaper, safer, easier to test and get approved, easier to upgrade and repair, and avoids patients needing to make a decision about the risk/benefit of surgery


  • Early detection of chemotherapy-induced peripheral neuropathy (CIPN) provides opportunities for treatment modification before permanent life-long damage ensues
  • Providing tactile feedback could significantly improve acceptance of prosthetic hands by users and therefore improve rehabilitation outcomes and the quality of life of amputees

Successful outcomes

  • Successfully conveyed tactile sense and supported direction judgements in small-scale trial
  • Early evidence from rat studies that chemotherapy-induced nerve damage in non-symptomatic animals can be detected

Capabilities and facilities

  • Skills in recording neu